SMSbiotech Featured in News for Groundbreaking COPD Therapy
We’re proud to announce that SMSbiotech and our flagship therapy — the Small Mobile Stem Cell (SMS Cell) — were recently spotlighted in a WBBJ‑TV news story titled “Doctor talks groundbreaking leap in fighting lung disease” (wbbjtv.com).
The article highlights the launch of our first human clinical trial for Chronic Obstructive Pulmonary Disease (COPD), following over a decade of preclinical research. Dr. Abdulkader Rahmo shared, “These cells have never been used in medicine… they could open up a new horizon for these applications in chronic diseases… with COPD we are talking 400 million people worldwide.”
The coverage emphasizes how SMS Cells are designed to regenerate damaged lung tissue — not just manage symptoms — underscoring the significance of our work and the potential impact of the SMS Cell platform for millions of patients worldwide.
Stay tuned for further updates as we advance through the clinical program and continue making breakthroughs in regenerative medicine.
https://www.wbbjtv.com/2025/05/14/doctor-talks-groundbreaking-leap-in-fighting-lung-disease/
